Chronic hypertension and left ventricular hypertrophy facilitate induction of sustained ventricular tachycardia in dogs 3 hours after left circumflex coronary artery occlusion-Reference-Cited by-同舟云学术

Chronic hypertension and left ventricular hypertrophy facilitate induction of sustained ventricular tachycardia in dogs 3 hours after left circumflex coronary artery occlusion

Published:1989-11 Issue:5 Volume:14 Page:1365-1373
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Martins James B.,Kim William,Marcus Melvin L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence and mortality in the Framingham study;Kannel;Ann Intern Med,1969

2. Role of blood pressure in cardiovascular morbidity and mortality;Kannel;Prog Cardiovasc Dis,1974

3. Precursors of sudden coronary death: factors related to the incidence of sudden death;Kannel;Circulation,1975

4. Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study;Rabkin;Am J Cardiol,1977

5. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs;Koyanagi;Circulation,1982

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is hypertensive left ventricular hypertrophy a cause of sustained ventricular arrhythmias in humans?;Journal of Human Hypertension;2021-03-05

2. Left Ventricular Hypertrophy and Arrhythmogenesis;Cardiac Electrophysiology Clinics;2015-06

3. Traditional Heart Failure Medications and Sudden Cardiac Death Prevention;Journal of Cardiovascular Pharmacology and Therapeutics;2013-06-13

4. Increased Left Ventricular Mass as a Predictor of Sudden Cardiac Death;Circulation: Arrhythmia and Electrophysiology;2013-02

5. Markers of Arrhythmogenic Risk in Hypertensive Subjects;Current Pharmaceutical Design;2011-09-01